{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:09:20Z","timestamp":1768568960808,"version":"3.49.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-023-00484-w","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T17:01:49Z","timestamp":1698771709000},"page":"47-65","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease"],"prefix":"10.1007","volume":"32","author":[{"given":"Gusti Putu Wahyunanda Crista","family":"Yuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naufa","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5851-3691","authenticated-orcid":false,"given":"Adam","family":"Hermawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"484_CR1","unstructured":"JHU. COVID-19 Map. In: Johns Hopkins Coronavirus Resource Center. 2022. https:\/\/coronavirus.jhu.edu\/map.html."},{"key":"484_CR2","unstructured":"NHS.\u00a0SARS (severe acute respiratory syndrome). 2022. https:\/\/www.nhs.uk\/conditions\/sars\/. Accessed 11 Feb 2022."},{"issue":"1","key":"484_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-020-00374-6","volume":"5","author":"TM Abd El-Aziz","year":"2020","unstructured":"Abd El-Aziz TM, Al-Sabi A, Stockand JD. Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID\u00ad19. Sig Transduct Target Ther. 2020;5(1):1\u20132. https:\/\/doi.org\/10.1038\/s41392-020-00374-6.","journal-title":"Sig Transduct Target Ther"},{"key":"484_CR4","unstructured":"Clinical\u00a0Trials. COVID-19 Clinical Trials Drug. 2022.https:\/\/clinicaltrials.gov\/ct2\/results?cond=2019nCoV&Search=Clear&age_v=&gndr=&type=&rslt=. Accessed 23 Jan 2022."},{"key":"484_CR5","unstructured":"Clinical Trials Arena. Coronavirus treatment: Vaccines\/drugs in the pipeline for COVID-19. 2022. https:\/\/www.clinicaltrialsarena.com\/analysis\/coronavirus-mers-cov-drugs\/. Accessed 21 Jan 2022.\u00a0"},{"key":"484_CR6","volume-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier JC, Parola P, Hoang VT, Medded L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial. 2020."},{"key":"484_CR7","unstructured":"RAPS. COVID-19 vaccine tracker. 2022. https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker. Accessed 23 Jan 2022."},{"key":"484_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.sciaf.2021.e00845","volume":"13","author":"AO Akinlalu","year":"2021","unstructured":"Akinlalu AO, Chamundi A, Yakumbur DT, Afolayan FID, Duru IA, Arowosegbe MA, et al. Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: an in silico study. Sci Afr. 2021;13:e00845. https:\/\/doi.org\/10.1016\/j.sciaf.2021.e00845.","journal-title":"Sci Afr"},{"issue":"12","key":"484_CR9","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1038\/s41380-021-01254-3","volume":"26","author":"N Hoertel","year":"2021","unstructured":"Hoertel N, S\u00e1nchez-Rico M, Cougoule C, Gulbins E, Kornhuber J, Carpinteiro A, et al. Repurposing antidepressants inhibiting the sphingomyelinase acid\/ceramide system against COVID-19: current evidence and potential mechanisms. Mol Psychiatry. 2021;26(12):7098\u20139. https:\/\/doi.org\/10.1038\/s41380-021-01254-3.","journal-title":"Mol Psychiatry"},{"issue":"14","key":"484_CR10","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1080\/07391102.2020.1784291","volume":"39","author":"M Kandeel","year":"2021","unstructured":"Kandeel M, Abdelrahman AHM, Oh-Hashi K, Ibrahim A, Venugopala KN, Morsy MA, et al. Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease. J Biomol Struct Dyn. 2021;39(14):5129\u201336. https:\/\/doi.org\/10.1080\/07391102.2020.1784291.","journal-title":"J Biomol Struct Dyn"},{"key":"484_CR11","doi-asserted-by":"crossref","unstructured":"Singh AK, Singh A, Dubey AK. Repurposed therapeutic strategies towards COVID-19 potential targets based on genomics and protein structure remodeling. IntechOpen. 2021.","DOI":"10.5772\/intechopen.96728"},{"issue":"4","key":"484_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","volume":"10","author":"MT Qamar","year":"2020","unstructured":"Qamar MT, Alqahtani SM, Alamri MA, Chen L-L. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10(4):313\u20139. https:\/\/doi.org\/10.1016\/j.jpha.2020.03.009.","journal-title":"J Pharm Anal"},{"key":"484_CR13","doi-asserted-by":"crossref","unstructured":"Lu J, Chen SA, Khan MB, Brassard R, Arutyunova E, Lamer T, et al. Crystallization of feline coronavirus Mpro with GC376 reveals mechanism of inhibition. Front Chem. 2022:10.","DOI":"10.3389\/fchem.2022.852210"},{"key":"484_CR14","doi-asserted-by":"publisher","unstructured":"Mahase E. Covid-19: Pfizer\u2019s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ. 2021;n2713. https:\/\/doi.org\/10.1136\/bmj.n2713.","DOI":"10.1136\/bmj.n2713"},{"key":"484_CR15","doi-asserted-by":"publisher","unstructured":"Mengist HM, Mekonnen D, Mohammed A, Shi R, Jin T. Potency, safety, and pharmacokinetic profiles of potential inhibitors targeting SARS-CoV-2 main protease. Front Pharmacol. 2021;11:630500. https:\/\/doi.org\/10.3389\/fphar.2020.630500.","DOI":"10.3389\/fphar.2020.630500"},{"issue":"1","key":"484_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-01577-x","volume":"4","author":"V Mody","year":"2021","unstructured":"Mody V, Ho J, Wills S, Mawri A, Lawson L, Ebert MCCJC, et al. Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents. Commun Biol. 2021;4(1):1\u201310. https:\/\/doi.org\/10.1038\/s42003-020-01577-x.","journal-title":"Commun Biol"},{"key":"484_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.amsu.2020.12.030","volume":"61","author":"K Sharun","year":"2020","unstructured":"Sharun K, Tiwari R, Dhama K. Protease inhibitor GC376 for COVID-19: lessons learned from feline infectious peritonitis. Ann Med Surg (Lond). 2020;61:122\u20135. https:\/\/doi.org\/10.1016\/j.amsu.2020.12.030.","journal-title":"Ann Med Surg (Lond)"},{"key":"484_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104228","volume":"145","author":"J Andreani","year":"2020","unstructured":"Andreani J, Le Bideau M, Duflot I, Jardot P, Rolland C, Boxberger M, et al. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. Microb Pathog. 2020;145:104228.","journal-title":"Microb Pathog"},{"key":"484_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2020.100684","volume":"35","author":"R Choudhary","year":"2020","unstructured":"Choudhary R, Sharma AK. Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance. New Microbes New Infect. 2020;35:100684.","journal-title":"New Microbes New Infect"},{"issue":"3","key":"484_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","volume":"59","author":"CM Chu","year":"2004","unstructured":"Chu CM, Cheng VCC, Hung IFN, Wong MML, Chan KH, Chan KS, et al. Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252\u20136. https:\/\/doi.org\/10.1136\/thorax.2003.012658.","journal-title":"Thorax."},{"issue":"3","key":"484_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269\u201371. https:\/\/doi.org\/10.1038\/s41422-020-0282-0.","journal-title":"Cell Res"},{"issue":"6","key":"484_CR22","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/bcp.14335","volume":"86","author":"H Javelot","year":"2020","unstructured":"Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C. COVID-19 and (hydroxy) chloroquine\u2013azithromycin combination: should we take the risk for our patients? Br J Clin Pharmacol. 2020;86(6):1176.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"484_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13321-018-0315-6","volume":"10","author":"D Gadaleta","year":"2018","unstructured":"Gadaleta D, Lombardo A, Toma C, Benfenati E. A new semi-automated workflow for chemical data retrieval and quality checking for modeling applications. J Cheminformatics. 2018;10(1):60. https:\/\/doi.org\/10.1186\/s13321-018-0315-6.","journal-title":"J Cheminformatics"},{"key":"484_CR24","unstructured":"DCIS. Daylight Theory: SMARTS - A Language for Describing Molecular Patterns. 2022. https:\/\/www.daylight.com\/dayhtml\/doc\/theory\/theory.smarts.html. Accessed 18 Apr 2022."},{"key":"484_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4155\/ebo.12.419","volume-title":"Silico drug discovery and design. Unitec house, 2 Albert place","author":"J Bajorath","year":"2013","unstructured":"Bajorath J. Machine learning and similarity-based virtual screening techniques. In: Silico drug discovery and design. Unitec house, 2 Albert place. London: Future Science Ltd; 2013. p. 134\u201346."},{"issue":"8","key":"484_CR26","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1021\/jm401411z","volume":"57","author":"G Maggiora","year":"2014","unstructured":"Maggiora G, Vogt M, Stumpfe D, Bajorath J. Molecular similarity in medicinal chemistry. J Med Chem. 2014;57(8):3186\u2013204. https:\/\/doi.org\/10.1021\/jm401411z.","journal-title":"J Med Chem"},{"key":"484_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ymeth.2014.08.005","volume":"71","author":"AC Massagu\u00e9","year":"2015","unstructured":"Massagu\u00e9 AC, Ojeda MJ, Valls C, Mulero M, Garcia-Vallv\u00e9 S, Pujadas G. Molecular fingerprint similarity search in virtual screening. Methods. 2015;71:58\u201363. https:\/\/doi.org\/10.1016\/j.ymeth.2014.08.005.","journal-title":"Methods."},{"issue":"14","key":"484_CR28","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK. Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem. 2012;55(14):6582\u201394. https:\/\/doi.org\/10.1021\/jm300687e.","journal-title":"J Med Chem"},{"key":"484_CR29","doi-asserted-by":"publisher","unstructured":"Cichonska A, Ravikumar B, Allaway RJ, Park S, Wan F, Isayev O, et al. Crowdsourced mapping extends the target space of kinase inhibitors. bioRxiv; 2020. p. https:\/\/doi.org\/10.1101\/2019.12.31.891812.","DOI":"10.1101\/2019.12.31.891812"},{"key":"484_CR30","unstructured":"PDB. Resolution - Proteopedia, life in 3D. 2022. https:\/\/proteopedia.org\/wiki\/index.php\/Resolution. Accessed 20 Apr 2022."},{"issue":"9","key":"484_CR31","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1021\/acs.jmedchem.5b01746","volume":"59","author":"Y Hu","year":"2016","unstructured":"Hu Y, Stumpfe D, Bajorath J. Computational exploration of molecular scaffolds in medicinal chemistry. J Med Chem. 2016;59(9):4062\u201376. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01746.","journal-title":"J Med Chem"},{"key":"484_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/B978-0-12-811654-8.00003-8","volume-title":"Temporal data mining via unsupervised ensemble learning","author":"Y Yang","year":"2017","unstructured":"Yang Y. Chapter 3 - temporal data clustering. In: Yang Y, editor. Temporal data mining via unsupervised ensemble learning. Elsevier; 2017. p. 19\u201334."},{"issue":"6","key":"484_CR33","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1021\/ci900049e","volume":"49","author":"SS Chaudhaery","year":"2009","unstructured":"Chaudhaery SS, Roy KK, Saxena AK. Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors. J Chem Inf Model. 2009;49(6):1590\u2013601. https:\/\/doi.org\/10.1021\/ci900049e.","journal-title":"J Chem Inf Model"},{"key":"484_CR34","unstructured":"Nighania K. Various ways to evaluate a machine learning models performance. Medium. 2019."},{"key":"484_CR35","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717. https:\/\/doi.org\/10.1038\/srep42717.","journal-title":"Sci Rep"},{"key":"484_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.115159","volume":"325","author":"A Kumar","year":"2021","unstructured":"Kumar A, Kumari K, Singh S, Bahadur I, Singh P. Noscapine anticancer drug designed with ionic liquids to enhance solubility: DFT and ADME approach. J Mol Liq. 2021;325:115159. https:\/\/doi.org\/10.1016\/j.molliq.2020.115159.","journal-title":"J Mol Liq"},{"issue":"9","key":"484_CR37","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires DEV, Blundell TL, Ascher DB. Pkcsm: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58(9):4066\u201372. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104.","journal-title":"J Med Chem"},{"issue":"1","key":"484_CR38","doi-asserted-by":"publisher","first-page":"13928","DOI":"10.1038\/s41598-022-18348-9","volume":"12","author":"A Hermawan","year":"2022","unstructured":"Hermawan A, Wulandari F, Hanif N, Utomo RY, Jenie RI, Ikawati M, et al. Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study. Sci Rep. 2022;12(1):13928. https:\/\/doi.org\/10.1038\/s41598-022-18348-9.","journal-title":"Sci Rep"},{"key":"484_CR39","doi-asserted-by":"publisher","unstructured":"Fu L, Ye F, Feng Y, Yu F, Wang Q, Wu Y, et al. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun. 2020;11(1) https:\/\/doi.org\/10.1038\/s41467-020-18233-x.","DOI":"10.1038\/s41467-020-18233-x"},{"issue":"3","key":"484_CR40","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1039\/D0MD00367K","volume":"12","author":"R Oerlemans","year":"2021","unstructured":"Oerlemans R, Ruiz-Moreno AJ, Cong Y, Kumar ND, Velasco-Velazquez MA, Neochoritis CG, et al. Repurposing the HCV NS3\u20134A protease drug boceprevir as COVID-19 therapeutics. RSC Med Chem. 2021;12(3):370\u20139. https:\/\/doi.org\/10.1039\/D0MD00367K.","journal-title":"RSC Med Chem"},{"issue":"1","key":"484_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/pro.3978","volume":"30","author":"R Oughtred","year":"2021","unstructured":"Oughtred R, Rust J, Chang C, Breitkreutz B-J, Stark C, Willems A, et al. The BioGRID database: a comprehensive biomedical resource of curated protein, genetic, and chemical interactions. Protein Sci. 2021;30(1):187\u2013200. https:\/\/doi.org\/10.1002\/pro.3978.","journal-title":"Protein Sci"},{"issue":"4","key":"484_CR42","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(4):S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11.","journal-title":"BMC Syst Biol"},{"issue":"11","key":"484_CR43","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"key":"484_CR44","unstructured":"Brownlee J. How to know if your machine learning model has good performance. Machine Learning Mastery. 2018."},{"issue":"5","key":"484_CR45","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/jmri.21947","volume":"30","author":"RH El Khouli","year":"2009","unstructured":"El Khouli RH, Macura KJ, Barker PB, Phil D, Habba MR, Jacobs MA, et al. The relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced (DCE) MRI of the breast. J Magn Reson Imaging. 2009;30(5):999\u20131004. https:\/\/doi.org\/10.1002\/jmri.21947.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"484_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22(3):276\u201382.","journal-title":"Biochem Med (Zagreb)"},{"issue":"7","key":"484_CR47","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.31557\/APJCP.2022.23.7.2341","volume":"23","author":"SNA Azzahra","year":"2022","unstructured":"Azzahra SNA, Hanif N, Hermawan A. MDM2 is a potential target gene of glycyrrhizic acid for circumventing breast cancer resistance to tamoxifen: integrative bioinformatics analysis. Asian Pac J Cancer Prev. 2022;23(7):2341\u201350. https:\/\/doi.org\/10.31557\/APJCP.2022.23.7.2341.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"484_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/his.13277","volume":"72","author":"AJ Gill","year":"2018","unstructured":"Gill AJ. Succinate dehydrogenase (SDH)-deficient neoplasia. Histopathology. 2018;72(1):106\u201316. https:\/\/doi.org\/10.1111\/his.13277.","journal-title":"Histopathology."},{"issue":"1","key":"484_CR49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12915-020-0764-z","volume":"18","author":"SJ Szymura","year":"2020","unstructured":"Szymura SJ, Bernal GM, Wu L, Zhang Z, Crawley CD, Voce DJ, et al. DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-\u03baB and sensitize to alkylating chemotherapy. BMC Biol. 2020;18(1):32. https:\/\/doi.org\/10.1186\/s12915-020-0764-z.","journal-title":"BMC Biol"},{"issue":"1","key":"484_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF-W Chan","year":"2020","unstructured":"Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. 2020;9(1):221\u201336. https:\/\/doi.org\/10.1080\/22221751.2020.1719902.","journal-title":"Microbes Infect"},{"issue":"5636","key":"484_CR51","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1126\/science.1085703","volume":"301","author":"R Belotserkovskaya","year":"2003","unstructured":"Belotserkovskaya R, Oh S, Bondarenko VA, Orphanides G, Studitsky VM, Reinberg D. FACT facilitates transcription-dependent nucleosome alteration. Science. 2003;301(5636):1090\u20133. https:\/\/doi.org\/10.1126\/science.1085703.","journal-title":"Science."},{"key":"484_CR52","doi-asserted-by":"publisher","unstructured":"Cui J, Wang L, Ren X, Zhang Y, Zhang H. LRPPRC: a multifunctional protein involved in energy metabolism and human disease. Front Physiol. 2019;10:595. https:\/\/doi.org\/10.3389\/fphys.2019.00595.","DOI":"10.3389\/fphys.2019.00595"},{"key":"484_CR53","doi-asserted-by":"publisher","unstructured":"Zhang H-R, Lai S-Y, Huang L-J, Zhang Z-F, Liu J, Zheng S-R, et al. Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer. Gynecol Oncol. 2018:149. https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.024.","DOI":"10.1016\/j.ygyno.2018.01.024"},{"issue":"1","key":"484_CR54","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1038\/ncomms4077","volume":"5","author":"HB Ngo","year":"2014","unstructured":"Ngo HB, Lovely GA, Phillips R, Chan DC. Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation. Nat Commun. 2014;5(1):3077. https:\/\/doi.org\/10.1038\/ncomms4077.","journal-title":"Nat Commun"},{"issue":"10","key":"484_CR55","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.15252\/embr.201642195","volume":"17","author":"K Zebrucka","year":"2016","unstructured":"Zebrucka K, Koryga I, Mnich K, Ljujic M, Samali A, Gorman A. The integrated stress response. EMBO Rep. 2016;17(10):1374\u201395. https:\/\/doi.org\/10.15252\/embr.201642195.","journal-title":"EMBO Rep"},{"key":"484_CR56","doi-asserted-by":"publisher","unstructured":"Amorim IS, Lach G, Gkogkas CG. The role of the eukaryotic translation initiation factor 4E (eIF4E) in neuropsychiatric disorders. Front Genet. 2018;9:561. https:\/\/doi.org\/10.3389\/fgene.2018.00561.","DOI":"10.3389\/fgene.2018.00561"},{"issue":"4","key":"484_CR57","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/acn3.51345","volume":"8","author":"R Romaniello","year":"2021","unstructured":"Romaniello R, Citterio A, Panzeri E, Arrigoni F, De Rinaldis M, Trabacca A, et al. Novel SPTBN2 gene mutation and first intragenic deletion in early onset spinocerebellar ataxia type 5. Ann Clin Transl Neurol. 2021;8(4):956\u201363. https:\/\/doi.org\/10.1002\/acn3.51345.","journal-title":"Ann Clin Transl Neurol"},{"issue":"10","key":"484_CR58","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.30645","volume":"4","author":"JH Becker","year":"2021","unstructured":"Becker JH, Lin JJ, Doernberg M, Stone K, Navis A, Festa JR, et al. Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. 2021;4(10):e2130645. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.30645.","journal-title":"JAMA Netw Open"},{"key":"484_CR59","doi-asserted-by":"publisher","unstructured":"Bora VR, Patel BM. The deadly duo of COVID-19 and cancer! Front Mol Biosci. 2021;8:643004. https:\/\/doi.org\/10.3389\/fmolb.2021.643004.","DOI":"10.3389\/fmolb.2021.643004"},{"issue":"1","key":"484_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","volume":"40","author":"S Hojyo","year":"2020","unstructured":"Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regener. 2020;40(1):37. https:\/\/doi.org\/10.1186\/s41232-020-00146-3.","journal-title":"Inflamm Regener"},{"key":"484_CR61","doi-asserted-by":"publisher","unstructured":"Liu Y-H, Chen Y, Wang Q-H, Wang L-R, Jiang L, Yang Y, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurology. 2022; https:\/\/doi.org\/10.1001\/jamaneurol.2022.0461.","DOI":"10.1001\/jamaneurol.2022.0461"},{"issue":"6","key":"484_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355\u201362. https:\/\/doi.org\/10.1038\/s41577-020-0331-4.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"484_CR63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jemermed.2020.10.010","volume":"60","author":"A Povlow","year":"2021","unstructured":"Povlow A, Auerbach AJ. Acute cerebellar ataxia in COVID-19 infection: a case report. J Emerg Med. 2021;60(1):73\u20136. https:\/\/doi.org\/10.1016\/j.jemermed.2020.10.010.","journal-title":"J Emerg Med"},{"issue":"6","key":"484_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202000331","volume":"43","author":"G Saini","year":"2021","unstructured":"Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays. 2021;43(6):e2000331. https:\/\/doi.org\/10.1002\/bies.202000331.","journal-title":"Bioessays."},{"issue":"9","key":"484_CR65","doi-asserted-by":"publisher","first-page":"F1288","DOI":"10.1152\/ajprenal.00316.2013","volume":"305","author":"T Sullivan","year":"2013","unstructured":"Sullivan T, Miao Z, Dairaghi DJ, Krasinski A, Wang Y, Zhao BN, et al. CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice. Am J Physiol Renal Physiol. 2013;305(9):F1288\u2013F97. https:\/\/doi.org\/10.1152\/ajprenal.00316.2013.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"484_CR66","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/jcm4061325","volume":"4","author":"MV Perez-Gomez","year":"2015","unstructured":"Perez-Gomez MV, Sanchez-Ni\u00f1o MD, Sanz AB, Mart\u00edn-Cleary C, Ruiz-Ortega M, Egido J, et al. Horizon 2020 in diabetic kidney disease: the clinical trial pipeline for add-on therapies on top of renin angiotensin system blockade. J Clin Med. 2015;4(6):1325\u201347. https:\/\/doi.org\/10.3390\/jcm4061325.","journal-title":"J Clin Med"},{"issue":"11","key":"484_CR67","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.metabol.2013.06.008","volume":"62","author":"TJ Sullivan","year":"2013","unstructured":"Sullivan TJ, Miao Z, Zhao BN, Ertl LS, Wang Y, Krasinski A, et al. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Metabolism. 2013;62(11):1623\u201332. https:\/\/doi.org\/10.1016\/j.metabol.2013.06.008.","journal-title":"Metabolism."},{"issue":"3","key":"484_CR68","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00280-020-04181-2","volume":"87","author":"MC Stipp","year":"2021","unstructured":"Stipp MC, Acco A. Involvement of cytochrome P450 enzymes in inflammation and cancer: a review. Cancer Chemother Pharmacol. 2021;87(3):295\u2013309. https:\/\/doi.org\/10.1007\/s00280-020-04181-2.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"23","key":"484_CR69","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","volume":"22","author":"M Zhao","year":"2021","unstructured":"Zhao M, Ma J, Li M, Zhang Y, Jiang B, Zhao X, et al. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci. 2021;22(23):12808. https:\/\/doi.org\/10.3390\/ijms222312808.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"484_CR70","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s42399-021-01014-y","volume":"3","author":"J Tao","year":"2021","unstructured":"Tao J, Aristotelidis R, Zanowick-Marr A, Chambers LC, McDonald J, Mylonakis EE, et al. Evaluation of the treatment efficacy and safety of remdesivir for COVID-19: a meta-analysis. SN Compr Clin Med. 2021;3(12):2443\u201354. https:\/\/doi.org\/10.1007\/s42399-021-01014-y.","journal-title":"SN Compr Clin Med"},{"key":"484_CR71","doi-asserted-by":"publisher","unstructured":"Aleissa MM, Silverman EA, Paredes Acosta LM, Nutt CT, Richterman A, Marty FM. New perspectives on antimicrobial agents: remdesivir treatment for COVID-19. Antimicrob Agents Chemother. 2020;65(1). https:\/\/doi.org\/10.1128\/AAC.01814-20.","DOI":"10.1128\/AAC.01814-20"},{"key":"484_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.791922","volume":"13","author":"G Wang","year":"2022","unstructured":"Wang G, Xiao B, Deng J, Gong L, Li Y, Li J, et al. The role of cytochrome P450 enzymes in COVID-19 pathogenesis and therapy. Front Pharmacol. 2022;13:791922. https:\/\/doi.org\/10.3389\/fphar.2022.791922.","journal-title":"Front Pharmacol"},{"issue":"3","key":"484_CR73","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5599\/admet.995","volume":"9","author":"C Stergiopoulos","year":"2021","unstructured":"Stergiopoulos C, Tsopelas F, Valko K. Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements. ADMET DMPK. 2021;9(3):191\u2013207. https:\/\/doi.org\/10.5599\/admet.995.","journal-title":"ADMET DMPK"},{"key":"484_CR74","doi-asserted-by":"publisher","unstructured":"Munawar S, Windley MJ, Tse EG, Todd MH, Hill AP, Vandenberg JI, et al. Experimentally validated pharmacoinformatics approach to predict herg inhibition potential of new chemical entities. Front Pharmacol. 2018:9. https:\/\/doi.org\/10.3389\/fphar.2018.01035.","DOI":"10.3389\/fphar.2018.01035"},{"key":"484_CR75","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1016\/j.csbj.2021.04.014","volume":"19","author":"S Kumar","year":"2021","unstructured":"Kumar S, Singh B, Kumari P, Kumar PV, Agnihotri G, Khan S, et al. Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity. Comput Struct Biotechnol J. 2021;19:1998\u20132017. https:\/\/doi.org\/10.1016\/j.csbj.2021.04.014.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"484_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.31138\/mjr.28.1.33","volume":"28","author":"A Theodoridou","year":"2017","unstructured":"Theodoridou A, Gika H, Diza E, Garyfallos A, Settas L. In vivo study of pro-inflammatory cytokine changes in serum and synovial fluid during treatment with celecoxib and etoricoxib and correlation with VAS pain change and synovial membrane penetration index in patients with inflammatory arthritis. MJR. 2017;28(1):33\u201340. https:\/\/doi.org\/10.31138\/mjr.28.1.33.","journal-title":"MJR."},{"key":"484_CR77","doi-asserted-by":"publisher","unstructured":"Prasher P, Sharma M, Gunupuru R. Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy. Drug Dev Res. 2021; https:\/\/doi.org\/10.1002\/ddr.21794.","DOI":"10.1002\/ddr.21794"},{"issue":"4","key":"484_CR78","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bj.2020.05.001","volume":"43","author":"Y-Y Ke","year":"2020","unstructured":"Ke Y-Y, Peng T-T, Yeh T-K, Huang W-Z, Chang S-E, Wu S-H, et al. Artificial intelligence approach fighting COVID-19 with repurposing drugs. Biom J. 2020;43(4):355\u201362. https:\/\/doi.org\/10.1016\/j.bj.2020.05.001.","journal-title":"Biom J"},{"issue":"11","key":"484_CR79","doi-asserted-by":"publisher","first-page":"E3793","DOI":"10.3390\/ijms21113793","volume":"21","author":"A Gimeno","year":"2020","unstructured":"Gimeno A, Mestres-Truyol J, Ojeda-Montes MJ, Macip G, Saldivar-Espinoza B, Cereto-Massagu\u00e9 A, et al. Prediction of novel inhibitors of the main protease (M-pro) of SARS-CoV-2 through consensus docking and drug reposition. Int J Mol Sci. 2020;21(11):E3793. https:\/\/doi.org\/10.3390\/ijms21113793.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"484_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bj.2020.11.005","volume":"44","author":"P Magro","year":"2021","unstructured":"Magro P, Zanella I, Pescarolo M, Castelli F, Quiros-Roldan E. Lopinavir\/ritonavir: repurposing an old drug for HIV infection in COVID-19 treatment. Biom J. 2021;44(1):43\u201353. https:\/\/doi.org\/10.1016\/j.bj.2020.11.005.","journal-title":"Biom J"},{"issue":"8","key":"484_CR81","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00003495-200363080-00004","volume":"63","author":"RS Cvetkovic","year":"2003","unstructured":"Cvetkovic RS, Goa KL. Lopinavir\/ritonavir. Drugs. 2003;63(8):769\u2013802. https:\/\/doi.org\/10.2165\/00003495-200363080-00004.","journal-title":"Drugs"},{"issue":"14","key":"484_CR82","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.2165\/11204950-000000000-00000","volume":"70","author":"JD Croxtall","year":"2010","unstructured":"Croxtall JD, Perry CM. Lopinavir\/ritonavir. Drugs. 2010;70(14):1885\u2013915. https:\/\/doi.org\/10.2165\/11204950-000000000-00000.","journal-title":"Drugs"},{"key":"484_CR83","doi-asserted-by":"publisher","unstructured":"Marzolini C, Stader F, Stoeckle M, Franzeck F, Egli A, Bassetti S, et al. Effect of systemic inflammatory response to SARS-CoV-2 on lopinavir and hydroxychloroquine plasma concentrations. Antimicrob Agents Chemother. 2020;64(9). https:\/\/doi.org\/10.1128\/AAC.01177-20.","DOI":"10.1128\/AAC.01177-20"},{"issue":"8","key":"484_CR84","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","volume":"30","author":"C Ma","year":"2020","unstructured":"Ma C, Sacco MD, Hurst B, Townsend JA, Hu Y, Szeto T, et al. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Res. 2020;30(8):678\u201392. https:\/\/doi.org\/10.1038\/s41422-020-0356-z.","journal-title":"Cell Res"},{"issue":"1","key":"484_CR85","doi-asserted-by":"publisher","first-page":"9609","DOI":"10.1038\/s41598-021-89013-w","volume":"11","author":"CJ C\u00e1ceres","year":"2021","unstructured":"C\u00e1ceres CJ, Cardenas-Garcia S, Carnaccini S, Seibert B, Rajao DS, Wang J, et al. Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model. Sci Rep. 2021;11(1):9609. https:\/\/doi.org\/10.1038\/s41598-021-89013-w.","journal-title":"Sci Rep"},{"issue":"10","key":"484_CR86","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1358\/dot.2011.47.10.1656503","volume":"47","author":"SA Rizza","year":"2011","unstructured":"Rizza SA, Talwani R, Nehra V, Temesgen Z. Boceprevir. Drugs of Today. 2011;47(10):743. https:\/\/doi.org\/10.1358\/dot.2011.47.10.1656503.","journal-title":"Drugs of Today"},{"issue":"21","key":"484_CR87","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1128\/JVI.01348-12","volume":"86","author":"Y Kim","year":"2012","unstructured":"Kim Y, Lovell S, Tiew K-C, Mandadapu SR, Alliston KR, Battaile KP, et al. Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J Virol. 2012;86(21):11754\u201362. https:\/\/doi.org\/10.1128\/JVI.01348-12.","journal-title":"J Virol"},{"issue":"7","key":"484_CR88","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/10611860310001648248","volume":"11","author":"R Didziapetris","year":"2003","unstructured":"Didziapetris R, Japertas P, Avdeef A, Petrauskas A. Classification analysis of P-glycoprotein substrate specificity. J Drug Target. 2003;11(7):391\u2013406. https:\/\/doi.org\/10.1080\/10611860310001648248.","journal-title":"J Drug Target"},{"issue":"10","key":"484_CR89","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3390\/antiox10101517","volume":"10","author":"C Mand\u00f2","year":"2021","unstructured":"Mand\u00f2 C, Savasi VM, Anelli GM, Corti S, Serati A, Lisso F, et al. Mitochondrial and oxidative unbalance in placentas from mothers with SARS-CoV-2 infection. Antioxidants. 2021;10(10):1517. https:\/\/doi.org\/10.3390\/antiox10101517.","journal-title":"Antioxidants."},{"issue":"1","key":"484_CR90","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/hep.30149","volume":"69","author":"G Refolo","year":"2019","unstructured":"Refolo G, Ciccosanti F, Di Rienzo M, Basulto Perdomo A, Romani M, Alonzi T, et al. Negative regulation of mitochondrial antiviral signaling protein-mediated antiviral signaling by the mitochondrial protein LRPPRC during hepatitis C virus infection. Hepatology. 2019;69(1):34\u201350. https:\/\/doi.org\/10.1002\/hep.30149.","journal-title":"Hepatology."},{"issue":"1","key":"484_CR91","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/cells11010080","volume":"11","author":"A Dong","year":"2022","unstructured":"Dong A, Zhao J, Griffin C, Wu R. The genomic physics of COVID-19 pathogenesis and spread. Cells. 2022;11(1):80. https:\/\/doi.org\/10.3390\/cells11010080.","journal-title":"Cells."},{"key":"484_CR92","doi-asserted-by":"publisher","unstructured":"McCarthy MK, Weinberg JB. The immunoproteasome and viral infection: a complex regulator of inflammation. Front Microbiol. 2015;6(1):630500. https:\/\/doi.org\/10.3389\/fphar.2020.630500.","DOI":"10.3389\/fphar.2020.630500"},{"issue":"7548","key":"484_CR93","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520(7548):553\u20137. https:\/\/doi.org\/10.1038\/nature14156.","journal-title":"Nature."},{"issue":"19","key":"484_CR94","doi-asserted-by":"publisher","first-page":"e00621","DOI":"10.1128\/JVI.00621-17","volume":"91","author":"H Sooryanarain","year":"2017","unstructured":"Sooryanarain H, Rogers AJ, Cao D, Haac MER, Karpe YA, Meng X-J. ISG15 modulates type I interferon signaling and the antiviral response during hepatitis E virus replication. J Virol. 2017;91(19):e00621\u201317. https:\/\/doi.org\/10.1128\/JVI.00621-17.","journal-title":"J Virol"},{"key":"484_CR95","doi-asserted-by":"crossref","unstructured":"Zhou D, Park J-G, Wu Z, Huang H, Fiches GN, Biswas A, et al. FACT subunit SUPT16H associates with BRD4 and contributes to silencing of antiviral interferon signaling. Mol Biol. 2021.","DOI":"10.1101\/2021.04.21.440833"},{"issue":"11","key":"484_CR96","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/s41593-021-00926-1","volume":"24","author":"J Wenzel","year":"2021","unstructured":"Wenzel J, Lampe J, M\u00fcller-Fielitz H, Schuster R, Zille M, M\u00fcller K, et al. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci. 2021;24(11):1522\u201333. https:\/\/doi.org\/10.1038\/s41593-021-00926-1.","journal-title":"Nat Neurosci"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-023-00484-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-023-00484-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-023-00484-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:26:29Z","timestamp":1715318789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-023-00484-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1007\/s40199-023-00484-w","relation":{},"ISSN":["2008-2231"],"issn-type":[{"value":"2008-2231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work does not involve any studies with human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}